DOTS in Haiti [2]

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 3, 2000, Pages 282-283

  Ollé Goig, Jaime E ^a  

^a NONE   (Dominican Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HAITI; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; LETTER; PRIORITY JOURNAL; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; DRUG EFFECT; INFECTION CONTROL; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS;

ISONIAZID; TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; HAITI; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034153481     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (17)

1. Forty-fourth World Health Assembly, Geneva, 6-16 May 1991. Resolutions and Decisions. WHA44/1991/REC/1. Geneva: World Health Organization, 1991.
2. TB - A global emergency. WHO/TB/94.177. Geneva: World Health Organization, 1994.
3. van Herten L M, van de Water H P A. New global health for all targets. BMJ 1999; 319: 700-704.
4. TB. A crossroads. WHO Report on the Global Tuberculosis Epidemic 1998. WHO/TB/98.247. Geneva: World Health Organization, 1998.
5. WHO report on the tuberculosis epidemic, 1997. Geneva: World Health Organization, 1997.
6. WHO/CPC/TB/99.259. Global Tuberculosis Report. WHO Report 1999. Geneva: World Health Organization, 1999.
7. Barry M, Stanfield S K, Bia F J. Haiti and the Hôpital Albert Schweitzer. Ann Intern Med 1983; 98: 1018-1020.
8. Ollé-Goig J E, Alvarez J. Evaluating a tuberculosis control programme in Haiti. Tubercle Lung Dis 1994; 75: S1.
9. Ollé-Goig J E, Alvarez J. Control of tuberculosis in a district of Haiti: directly observed vs non-observed therapy. Int J Tuberc Lung Dis 1997; 1: S68.
10. Ollé-Goig J E, Alvarez J. Treatment of tuberculosis in a rural area of Haiti: directly observed versus non observed therapy. The experience of the Hôpital Albert Schweitzer. (submitted for publication).
11. Maher D, van Gorkom J L C, Gondrie P C F M, Raviglione M. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int J Tuberc Lung Dis 1999; 3: 762-768.
12. Han N T, Thi D, Nhien T. A comparison of treatment result and the cost effectiveness of regimen 2SHRZ/4HR with the regimen 2SHRZ/6HE in new smear-positive tuberculosis patients. Int J Tuherc Lung Dis 1999; 3 (Suppl 1): S51.
13. Long R, Scalcini M. Is the treatment of WHO Category I tuberculosis with 2HRZE/6HE a defensible practice? Int J Tuberc Lung Dis 1999; 3: 747-748.
14. Scalcini M, Carré G, Jean-Baptiste M, et al. Antituberculous drug resistance in Central Haiti. Am Rev Respir Dis 1990; 142: 508-511.
15. Tsogt G, Levy M, Sudre P, Norval P-Y, Spinaci S. DOTS pilot project in Mongolia, 1995. Int J Tuberc Lung Dis 1999; 3: 886-890.
16. Ollé-Goig J E. Control of multidrug resistant tuberculosis: DOTS-plus strategy will be hard to implement. BMJ 1999; 318: 736.
17. Reichman L B. Tuherculosis elimination - what's to stop us? Int J Tuberc Lung Dis 1997; 1: 3-11.